Skip to main navigation Skip to search Skip to main content

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Elafibranor in Patients with Nonalcoholic Steatohepatitis (NASH) and fibrosis

University at Buffalo

Project: Research

Project Details

StatusFinished
Effective start/end date04/16/18 → 04/16/22

Funding

  • Genfit SA: $76,036.00